From the Research
Apart (Insulin Aspart) has better glucose control compared to Lipitor (Atorvastatin) is not a relevant comparison, as Lipitor is a statin and not an insulin or glucose control medication. However, considering the provided evidence, it's clear that the question is likely intended to compare the glucose control effects of different insulins, not statins like Atorvastatin. Among the insulins discussed in the evidence, such as Insulin Aspart, the most recent and highest quality study 1 compares Fiasp (an ultrarapid-acting insulin) to Insulin Aspart in hospitalized patients with type 2 diabetes, showing that Fiasp provides noninferior postprandial glucose control with no increase in hypoglycemia rates. For optimal glucose control with Insulin Aspart or similar rapid-acting insulins:
- Inject immediately before meals
- Start with an appropriate dose based on the patient's total daily insulin dose and meal composition
- Adjust dose based on pre-meal and post-meal glucose readings It's essential to note that Atorvastatin (Lipitor) is used to lower cholesterol and does not directly affect glucose control. The management of diabetes involves medications that directly influence glucose levels, such as insulins and oral hypoglycemic agents. The choice of insulin should be based on the individual patient's needs, including the type of diabetes, lifestyle, and ability to monitor and adjust insulin doses. Close monitoring and dose adjustments are crucial when initiating or switching between insulins to achieve optimal glucose control and minimize the risk of hypoglycemia.